AMPAC Home NSTC

AMPAC News

July 2017

UCF, Nemours Collaborate to Defeat Difficult-to-Treat Childhood Cancer

Photo

Attaching curcumin, a component of the common spice turmeric, to nanoparticles can be used to target and destroy treatment-resistant neuroblastoma tumor cells, according to a new study published in Nanoscale. The study, conducted in partnership by researchers at Nemours Children’s Hospital and the University of Central Florida, demonstrates a potentially novel treatment for neuroblastoma, the most common cancer in infants.

“High-risk neuroblastoma can be resistant to traditional therapy, and survival can be poor. This research demonstrates a novel method of treating this tumor without the toxicity of aggressive therapy that can also have late effects on the patient’s health,” said Tamarah J. Westmoreland, MD, PhD, a pediatric surgeon at Nemours Children’s Health System and senior author of the study. “Unique approaches to target tumor cells with nanoparticle delivery systems hold promise for treatment of resistant tumors, such as the high risk neuroblastoma. We are hopeful that in the future, nanoparticles can be utilized to personalize care to patients and reduce the late effects of therapy.”

Read more at UCF Today

UCF Advanced Materials Processing and Analysis Center | Engineering Building 1, Room 208 | TEL: (407) 882-1455 FAX: (407) 882-1462
4000 Central Florida Blvd. Box 162455, Orlando, Florida, 32816 | AMPAC@ucf.edu
NanoScience Technology Center